The potential clinical utility of serial plasma albumin mRNA monitoring for the post-liver transplantation management

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1313-1319

  Chan, Rebecca Wing Yan ^a   Wong, John ^a   Lai, Paul Bo Shan ^a   Lo, Yuk Ming Dennis ^a   Chiu, Rossa Wai Kwun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Albumin mRNA; Circulating RNA; Liver transplantation; Plasma mRNA

Indexed keywords

ALANINE AMINOTRANSFERASE; MESSENGER RNA; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; PATIENT MONITORING; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ALBUMIN MRNA; CIRCULATING RNA; LIVER TRANSPLANTATION; PLASMA MRNA;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHOLANGITIS; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN;

EID: 84884309790     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.04.022     Document Type: Article

References (31)

1. Lo Y.M., Chiu R.W. The biology and diagnostic applications of plasma RNA. Ann N Y Acad Sci 2004, 1022:135-139.
2. Lo Y.M., Chan L.Y., Lo K.W., Leung S.F., Zhang J., Chan A.T., et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999, 59:1188-1191.
3. Chan K.C., Lai P.B., Mok T.S., Chan H.L., Ding C., Yeung S.W., et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem 2008, 54:1528-1536.
4. Yung T.K., Chan K.C., Mok T.S., Tong J., To K.F., Lo Y.M. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res 2009, 15:2076-2084.
5. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
6. Lo Y.M.D., Chiu R.W.K. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007, 8:71-77.
7. Lo Y.M. Fetal nucleic acids in maternal plasma. Ann N Y Acad Sci 2008, 1137:140-143.
8. Chiu R.W., Chan K.C., Gao Y., Lau V.Y., Zheng W., Leung T.Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008, 105:20458-20463.
9. Lo Y.M., Chiu R.W. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications. J Pathol 2010, 225:318-323.
10. Chan K.C., Ding C., Gerovassili A., Yeung S.W., Chiu R.W., Leung T.N., et al. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006, 52:2211-2218.
11. Lo Y.M. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. BJOG 2009, 116:152-157.
12. Y.K. Tong, R.W. Chiu, R. Akolekar, T.Y. Leung, T.K. Lau, K.H. Nicolaides, Y.M. Lo, Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker, PLoS One 5 e15244.
13. Ng E.K., Tsui N.B., Lau T.K., Leung T.N., Chiu R.W., Panesar N.S., et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A 2003, 100:4748-4753.
14. Tsui N.B., Ng E.K., Lo Y.M. Molecular analysis of circulating RNA in plasma. Methods Mol Biol 2006, 336:123-134.
15. Lo Y.M., Tsui N.B., Chiu R.W., Lau T.K., Leung T.N., Heung M.M., et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007, 13:218-223.
16. Chan R.W., Wong J., Chan H.L., Mok T.S., Lo W.Y., Lee V., et al. Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies. Clin Chem 2010, 56:82-89.
17. Chan R.W., Graham C.A., Rainer T.H., Lam N.Y., Chiu R.W., Chik K.W., et al. Use of a bone marrow transplantation model system to demonstrate the hematopoietic origin of plasma S100B mRNA. Clin Chem 2007, 53:1874-1876.
18. Wong I.H., Lau W.Y., Leung T., Johnson P.J. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000, 156:141-149.
19. Chelly J., Concordet J.P., Kaplan J.C., Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A 1989, 86:2617-2621.
20. Dawwas M.F., Gimson A.E., Lewsey J.D., Copley L.P., van der Meulen J.H. Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut 2007, 56:1606-1613.
21. Freeman R.B., Steffick D.E., Guidinger M.K., Farmer D.G., Berg C.L., Merion R.M. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008, 8:958-976.
22. Humar A., Beissel J., Crotteau S., Kandaswamy R., Lake J., Payne W. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type. Transplantation 2008, 85:1420-1424.
23. Lee K.W., Cameron A.M., Maley W.R., Segev D.L., Montgomery R.A. Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base. Am J Transplant 2008, 8:1186-1196.
24. Nemes B., Polak W., Ther G., Hendriks H., Kobori L., Porte R.J., et al. Analysis of differences in outcome of two European liver transplant centers. Transpl Int 2006, 19:372-380.
25. Chiu R.W., Poon L.L., Lau T.K., Leung T.N., Wong E.M., Lo Y.M. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001, 47:1607-1613.
26. Heung M.M., Tsui N.B., Leung T.Y., Lau T.K., Lo Y.M., Chiu R.W. Development of extraction protocols to improve the yield for fetal RNA in maternal plasma. Prenat Diagn 2009, 29:277-279.
27. Wong B.C., Chiu R.W., Tsui N.B., Chan K.C., Chan L.W., Lau T.K., et al. Circulating placental RNA in maternal plasma is associated with a preponderance of 5' mRNA fragments: implications for noninvasive prenatal diagnosis and monitoring. Clin Chem 2005, 51:1786-1795.
28. Fournie G.J., Martres F., Pourrat J.P., Alary C., Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993, 39:215-221.
29. Fournie G.J., Courtin J.P., Laval F., Chale J.J., Pourrat J.P., Pujazon M.C., et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995, 91:221-227.
30. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61:1659-1665.
31. Trull A.K., Facey S.P., Rees G.W., Wight D.G., Noble-Jamieson G., Joughin C., et al. Serum alpha-glutathione S-transferase - a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation 1994, 58:1345-1351.